about
Comparison of frequency of insulin resistance in patients with chronic obstructive pulmonary disease with normal controls.The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.Strategies to manage hepatitis C virus infection disease burden - volume 3.Insulin resistance in non-diabetic patients of chronic Hepatitis C.Pyrazinamide induced hyperuricemia in patients taking anti-tuberculous therapy.Frequency of dual tuberculosis/human immunodeficiency virus infection in patients presenting at tertiary care centers at karachi.Risk factors for perinatal deaths in Pakistan.Comparison of heart rate and QTc duration in patients of cirrhosis of liver with non-cirrhotic controlsFrequency and comparative analysis of hapatitis D in petients seeking treatment for hepatitis BStroke scale score and early prediction of outcome after strokeFrequency of Helicobacter pylori antibodies in porto-systemic encephalopathyTreatment outcome in patients of hepatitis B with hepatitis D: experience of 4 years at a tertiary care centre in PakistanHemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liverHemogolbin, ferritin, vitamin B12 and halicobacter pylori infection: a study in patients who underwent upper gi endoscopy at civil hospital karachiCorrelation between clinical endoscopic and histological findings at esophago-gastric junction in patients of gastroesophageal reflux diseaseImpact of bowel preparation on caecal intubation time during colonoscopyCorrelation between Serum Ferritin Levels and Liver Stiffness measured by Fibroscan in patients with Chronic Hepatitis C
P50
Q36552979-ABC231C1-EB9C-42EB-B2FC-7AD91427B63FQ38948615-4C05A0FF-B9F8-4E02-A02B-FB42C9F860E1Q38948620-976305C5-6C28-45E0-93A5-02544C65B028Q40932583-20176EF3-4BD4-40E4-8890-DE4CEC472C60Q42024080-1FF6F0C3-49FE-4D26-969F-752FF19E1F1FQ44959977-DA9F8A84-2873-472D-8CB2-4F9EC8900B55Q45399291-C5CD085D-C131-463E-8CF7-1675FCB17791Q47838203-CFB0BE82-1C90-409E-BBB1-DB4237855F64Q79747905-836B09B1-708B-47BF-8605-0AF1D4FB1E7FQ80196959-8E58781B-4DD9-4598-8F10-0CF3BD6444B6Q80260678-2B160421-4DB5-4E27-AFAC-B1512FCE8052Q80537391-BCC3ED5C-25E9-46D5-A728-3CDF81CC8B6DQ80595199-70D639CA-FCD6-4162-A528-451F8C2ED841Q80595258-5D1CEF33-3104-4094-9D7A-DE6EC7E39468Q81369702-074DA949-01AE-406D-BA88-C449502A0769Q82202380-7430C7D1-2D31-4D6E-AEC9-0620A3EC3BC2Q91501714-B7BD0CCC-603A-4E5E-95E2-B6C64F7349D7Q91942641-92890346-CF75-40DF-9676-842E6DF93789
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Bader Faiyaz Zuberi
@en
Bader Faiyaz Zuberi
@nl
type
label
Bader Faiyaz Zuberi
@en
Bader Faiyaz Zuberi
@nl
prefLabel
Bader Faiyaz Zuberi
@en
Bader Faiyaz Zuberi
@nl
P108
P31
P496
0000-0001-7695-3922